Luca Roncati, MD-PhD, DMLS, is Associate Editor of the European Journal of Gynaecological Oncology (EJGO), Medical Executive at the University Hospital of Modena, and Adjunct Professor at the University of Modena and Reggio Emilia (Italy). Eponym of the Roncati-Manenti triad and describer of T rex lymphoma, he is the author of more than 250 academic publications, he has taken part in the scientific work of various national and international agencies or research groups, he has organized several conferences of national relevance, he has attended as a speaker at numerous congresses and seminars, he holds the intellectual property of an Italian and international patent for anticancer therapy, and he has obtained various national and supranational awards.
